The ubiquitin-editing enzyme A20 controls NK cell homeostasis through regulation of mTOR activity and TNF

Author:

Vetters Jessica1234,van Helden Mary J.14,Wahlen Sigrid5,Tavernier Simon J.14ORCID,Martens Arne67,Fayazpour Farzaneh234,Vergote Karl14,Vanheerswynghels Manon14,Deswarte Kim14,Van Moorleghem Justine14,De Prijck Sofie14,Takahashi Nozomi68,Vandenabeele Peter68ORCID,Boon Louis9ORCID,van Loo Geert67ORCID,Vivier Eric1011ORCID,Lambrecht Bart N.13412ORCID,Janssens Sophie234ORCID

Affiliation:

1. Laboratory of Immunoregulation and Mucosal Immunology, VIB Center for Inflammation Research, Ghent, Belgium

2. Laboratory for Endoplasmic Reticulum Stress and Inflammation, VIB Center for Inflammation Research, Ghent, Belgium

3. GROUP-ID Consortium, Ghent University and Ghent University Hospital, Ghent, Belgium

4. Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium

5. Department of Diagnostic Sciences, Ghent University, Ghent, Belgium

6. Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium

7. Cellular and Molecular (Patho)physiology, VIB Center for Inflammation Research, Ghent, Belgium

8. Molecular Signaling and Cell Death, VIB Center for Inflammation Research, Ghent, Belgium

9. Bioceros BV, Utrecht, Netherlands

10. Innate Pharma Research Laboratories, Innate Pharma, Marseille, France

11. Aix-Marseille University, Assistance Publique–Hôpitaux de Marseille, Centre d'Immunologie de Marseille-Luminy, Hôpital de la Timone, Marseille Immunopôle, Marseille, France

12. Department of Pulmonary Medicine, Erasmus University Medical Center, Rotterdam, Netherlands

Abstract

The ubiquitin-editing enzyme A20 is a well-known regulator of immune cell function and homeostasis. In addition, A20 protects cells from death in an ill-defined manner. While most studies focus on its role in the TNF-receptor complex, we here identify a novel component in the A20-mediated decision between life and death. Loss of A20 in NK cells led to spontaneous NK cell death and severe NK cell lymphopenia. The few remaining NK cells showed an immature, hyperactivated phenotype, hallmarked by the basal release of cytokines and cytotoxic molecules. NK-A20−/− cells were hypersensitive to TNF-induced cell death and could be rescued, at least partially, by a combined deficiency with TNF. Unexpectedly, rapamycin, a well-established inhibitor of mTOR, also strongly protected NK-A20−/− cells from death, and further studies revealed that A20 restricts mTOR activation in NK cells. This study therefore maps A20 as a crucial regulator of mTOR signaling and underscores the need for a tightly balanced mTOR pathway in NK cell homeostasis.

Funder

Bijzonder Onderzoeksfonds

University of Ghent

European Research Council

ERC

Research Foundation Flanders

H2020 European Research Council

Agence Nationale de la Recherche

Ligue Contre le Cancer

MSDAvenir

Innate Pharma

INSERM

Centre National de la Recherche Scientifique

Aix-Marseille Université

Methusalem

Publisher

Rockefeller University Press

Subject

Immunology,Immunology and Allergy

Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3